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AxillaAbstract Purpose: The purpose of this study is to compare 2D plan and 3D plan regarding cov-
erage of the target (supraclavicular and infraclavicular regions) and dose reaching the risk organs
(using mean DVH).
Depending on the results of this study, modiﬁcations can be made to the 2D conventional planning
of supraclavicular and infraclavicular regions in order to achieve better coverage of the target tis-
sues.
Materials and methods: This is a dosimetric study carried out at the radiation oncology department
in NCI-Cairo University in the period from January 2012 to October 2012, on 15 patients with
breast cancer who are eligible for supraclavicular and infraclavicular irradiation. For All patients,
a 2D and a 3D plan were done.
Results: We found that the coverage of the supraclavicular and infraclavicular regions and the
chest wall or breast together with levels I and II axilla (PTV) were signiﬁcantly better with the
3D technique with less over dose than the 2D technique. That difference was highly signiﬁcant
and was most evident in MRM cases.
Also we found that organs at risk received a dose in the 3D technique that was more than that
received in the 2D technique, again that difference was highly signiﬁcant and was also most evident
in MRM cases but all doses were still within tolerance.
Conclusions: From the present study we concluded that the coverage of the supraclavicular and
infraclavicular PTV is signiﬁcantly worse with the 2D technique using a single oblique ﬁeld at a
ﬁxed depth of 3 cm for all patients despite their different builts.
ª 2014 Production and hosting by Elsevier B.V. on behalf of National Cancer Institute, Cairo University.
Figure 1 A MRM breast cancer patient placed over an elevated
breast board while both her arms are abducted and externally
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Breast cancer remains the most common cancer in women; it
constitutes 33% of all female patients at NCI and 50% in
the private series, [1]. Fortunately, breast cancer mortality
rates have declined continuously since 1990, with improved
survival in the last 20 years [2–4].
Postmastectomy irradiation has been proven to reduce the
15-year isolated locoregional recurrence rate for patients with
lymph node–positive disease from 29% to 8% [5].
A more revolutionary ﬁnding was that this signiﬁcant abso-
lute improvement in locoregional control reduced the 15-year
breast cancermortality rate.
Radiotherapy treatment ﬁelds are usually tangential to
encompass the breast, and, in some cases, matched to a supra-
clavicular ﬁeld, by using a single-plane hand-generated con-
tour through the center of the breast (2D planning). This
conventional two-dimensional RT breast plans can produce
substantial dose inhomogeneities, particularly in women with
larger breast [6]. According to ICRU-50 guidelines, an optimal
plan is one in which the entire planning target volume (PTV) is
between 95% and 107% levels relative to 100% prescription
point [7]. The main difﬁculty with tangential ﬁeld breast irradi-
ation is in the achievement of homogeneous dose distribution
inside the target volume.
The introduction of CT scanning and the availability of
sophisticated three-dimensional treatment planning methods
have improved the delivery of radiation to the breast and
peripheral lymphatics efﬁciently [8]. With the availability of
a CT-scanner, most of the centers are gradually shifting
toward CT-based treatment planning. More often, CT-based
three-dimensional treatment planning allows the planner and
physician to evaluate the dosimetry across the entire ﬁeld.
Consequently the plan can be optimized to limit lung and
other critical organ volume with selective blocking and min-
imize hot spots by using a higher energy and lesser wedge
angle.
Aim of work
In this dosimetric study we work on plans of 15 patients with
breast cancer who were eligible for comprehensive breast irra-
diation (including supraclavicular and infraclavicular ﬁelds)
for which a 2D and a 3D plan were done.
The aim was to
1. Compare both plans regarding coverage of the targets espe-
cially the (supraclavicular and infraclavicular regions) and
the dose reaching the risk organs (using mean DVH).
2. On basis of results of this study, modiﬁcations can be made
to the 2D conventional planning of supraclavicular and
infraclavicular regions in order to achieve a better coverage
of the target tissues.
Patients and methods
This is a dosimetric study carried out at the radiation oncology
department–NCI–Cairo University in the period from January2012 to October 2012, on 15 patients with breast cancer.
Patients eligible for the study were females aged more than
18 years who underwent either modiﬁed radical mastectomy,
or conservative breast surgery for stage III breast in whom
comprehensive radiotherapy was given including supraclavicu-
lar and infraclavicular regions.
Treatment
Immobilization
The patient should be immobilized with the ipsilateral arm
abducted (90–120) and externally rotated. The preferred
arm position is for the bilateral arms to be abducted and exter-
nally rotated, which allows for more precise matching of the
ipsilateral irradiated ﬁeld if the contralateral breast requires
radiation in the future (Fig. 1).
Data acquisition
Radio-opaque wire markings were placed along the midline,
the mid axillary line, the upper border of the chest wall ﬁeld
(the lower border of clavicular head) and along lower border
(in case of modiﬁed radical mastectomy: below the level of
contralateral infra mammary fold by 2 cm or in case of conser-
vative breast surgery: below the level of lowest breast tissue by
2 cm). A scout ﬁlm was taken for the patient in order to assure
proper anatomical borders and proper alignment of the patient
(Fig. 2). Serial CT cuts were scanned for the patient from
approximately the level of the angle of the mandible down till
L1 (to include the whole ipsilateral lung), every 2.5 mm using a
General Electric multi slice CT simulator after injection of IV
contrast (1 ml/kg of patient weight) (Fig. 3). All cuts are trans-
ferred to a General Electric Advantage workstation (Release
4.4).
Delineation
The target volumes were delineated for the patient according
to the RTOG guidelines.rotated holding the rod.
Figure 2 A scout ﬁlm for a patient with breast cancer.
2D and 3D planning for irradiation of supraclavicular and infraclavicular regions 27Outer body contour is delineated using auto-contouring
tool. The clinical target volume (CTV) was delineated (Figs. 4
and 5).
Then the positions of critical organs such as the spinal cord,
brachial plexus, lungs and heart are drawn directly into the
planning computer on a set of CT images covering the full
extent of the involved area (Figs. 4 and 5).
Then a margin of 8 mm was added around CTV of the
supraclavicular region and level III axilla as PTV, also a mar-
gin of 1 cm was added around the breast/chest wall as PTV
(Figs. 4 and 5).
The delineated CT cuts are then transferred to a Precise
PLAN treatment planning computer system (Release 2.12)
for constructing the 2D and 3D treatment plans for compre-
hensive breast irradiation.
2D treatment planning
Standard tangential ﬁelds including the breast or chest wall
anatomically may cover some but not all of level I and level
II (lower) axillary nodes and a single anterior oblique ﬁeld at
a ﬁxed depth of 3 cm for the supraclavicular and infraclavicu-
lar regions angled 10–15 away from the cervical spine.
3D treatment planning
Beams were used in the most optimal way for every patient to
produce the best coverage of the target tissues together with
the least dose to the surrounding organs at risk.
Two opposing tangential beams were constructed and with
the use of beam’s-eye-view projections, gantry angles were
adjusted and shielding was adapted with use of a multileaf col-
limator (MLC). Wedges, beam copies and/or a maximum of
two MLC segments were added. Regarding the supraclavicular
region, we used three wedged photon beams with different
weighing and angulations.Dose calculation and optimization
Organ at risk Dose constraint according to
the QUANTEC Review, 2010 [9]
End point
Lungs V20 (volume to which
20 Gy are delivered) should
be less than or equal to 30%
Symptomatic
pneumonitis
Heart V25 should be less than 10% Long term
cardiac mortality
Spinal cord D max should be less than 50 Gy MyelopathyThe maximum dose to brachial plexus was suggested by
Emami et al. 1991 as 60–66 Gy [10], a ﬁgure which was fol-
lowed in our study.
Then a DVH was created for the CTV, PTV and the organs
at risk (OARs) for each patient for the 2D plan and the 3D
plan.
Then the two DVHs constructed for OARs, CTV and PTV
for the conformal technique, and the other for an AP–PA tech-
nique were exported from the Precise treatment planning com-
puter system and averaged using Microsoft Excel to produce a
‘mean’ DVH for each organ or volume, the percentage volume
receiving different doses was calculated and then averaged over
the 15 patients to obtain a ‘mean’ value. These values were
then plotted to produce a mean DVH.
Statistical methods
SPSS 21 was used for data analysis. McNemar test was used
for comparing paired proportion with p-value <0.05 consid-
ered as signiﬁcant.
Results
The study included 15 female patients of different age groups
and pathologies, ﬁve of which had left CBS, 5 had right
CBS, 2 had right MRM, and 3 had left MRM. They were all
indicated for supraclavicular and infraclavicular irradiation.
For each patient, two treatment plans were done, one for
2D irradiation and the other for 3D irradiation. After creating
a mean DVH for the 3D plans of the 15 patients and for the
2D plans of the 15 patients, both DVHs were compared and
the following results were reached:
PTV of supraclavicular and infraclavicular regions
In 2D planning, the mean of the radiation dose to the PTV was
4109.062 cGy (SD ± 1605.087), while in 3D planning the
mean was 4902.132 cGy (SD ± 1134.469).
In the whole group of patients, there was better coverage of
the target with the 3D technique, 95% of the target was cov-
ered by more than 95% of the dose, versus 50% only of the
target in 2D technique covered by 95% of the dose
(p= 0.001). In the 3D technique, the over dose reached
55 Gy (110% of the dose) (point dose), while in the 2D tech-
nique the over dose reached 61 Gy (122% of the dose) (point
dose) (Fig. 6).
Figure 3 Serial CT cuts of a breast cancer patient with MRM.
Figure 4 A CT cut showing a delineated chest wall of a breast
cancer patient with MRM (blue color: chest wall CTV, orange:
PTV, green: right lung, purple: left lung, yellow: heart).
Figure 5 A CT cut showing a delineated SCV and level III axilla
of a breast cancer patient (blue color: supraclavicular and level III
CTV, red: PTV, orange: spinal cord).
28 M. Barsoum et al.On further analysis this ﬁnding was consistent in the two
groups who had either CBS or MRM (Figs. 7 and 8).PTV of the chest wall or breast with levels I and II of the axilla
In 2D planning, the mean of the radiation dose to the PTV was
4521.406 cGy (SD ± 1586.054), while in 3D planning the
mean was 4926.804 cGy (SD ± 1175.299).
Figure 6 Mean DVH of supraclavicular and infraclavicular regions PTV in 2D and 3D techniques in the whole group of patients (15
patients).
Figure 7 Mean DVH of supraclavicular and infraclavicular regions PTV in 2D and 3D techniques of CBS cases (10 patients).
Figure 8 Mean DVH of supraclavicular and infraclavicular regions PTV in 2D and 3D techniques of MRM cases (5 patients).
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of the target with the 3D technique, 90% of the target was cov-
ered by about 95% of the dose, versus only 65–70% of the tar-
get in 2D technique covered by 95% of the dose (p< 0.001).
In the 3D technique, the over dose reached about 58 Gy(116% of the dose) (point dose), while in the 2D technique
the over dose reached about 65 Gy (130% of the dose) (point
dose) (Fig. 9).
This ﬁnding was consistent for both groups of surgical pro-
cedures CBS or MRM.
Figure 9 Mean DVH of PTV of the chest wall or breast with levels I and II of the axilla in 2D and 3D techniques in the whole group of
patients (15 patients).
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According to QUANTEC, 2010 guidelines, V25 (volume of the
target subjected to 25 Gy) should be less than 10% and V30
should be less than 46% to avoid cardiac complications.
In 2D planning, the mean of the radiation dose to the heart
was 338.6 cGy (SD ± 613.3), while in 3D planning the mean
was 612.1 cGy (SD± 867.3).
In the whole group of patients, whether they had CBS or
MRM, in the 3D technique, the V25 and V30 were both
<5% of the volume.
On the other hand, in the 2D technique, the V25 was also
<5% of the volume and the V30 was 0% (p< 0.001)
(Fig. 10).
On further analysis for left sided breast cancer cases we
found that in 3D technique, the V25 was between 5% and
10% of the volume, while V30 was 5%. On the other hand,
in the 2D technique, the V25 and V30 were both less than
5% of the volume (p< 0.001) (Fig. 11).
Left lung and right lung
According to QUANTEC, 2010 guidelines, V20 < 30% i.e.
the volume of the target subjected to 20 Gy should be less thanFigure 10 Mean DVH of heart in 2D and 3D techn30% to avoid symptomatic pneumonitis which may occur in
less than 20% of cases.
Left lung
In 2D planning, the mean of the radiation dose to the left lung
was 678.081 cGy (SD ± 880.248), while in 3D planning the
mean was 1011.8479 cGy (SD ± 1188.194).
In the whole group of patients, in the 3D technique, the V20
of the left lung was <25% of the volume, while in the 2D tech-
nique, the V20 was <20% of the volume (p< 0.001) (Fig. 12).
This signiﬁcant difference was maintained in both CBS and
MRM groups. That difference was more prominent in MRM
cases, but all were still within tolerance.
Right lung
In 2D planning, the mean of the radiation dose to the right
lung was 794.433 cGy (SD± 001.589), while in 3D planning
the mean was 1021.428 cGy (SD ± 1206.461).
While regarding the right lung, in the whole group of
patients, the V20 was <25% of the volume in the 3D tech-
nique, while in the 2D technique, the V20 was about 10% of
the volume (p< 0.001) (Fig. 13).
In MRM cases where the dose reaching the right lung in the
3D technique was the highest possible dose within the toler-iques in the whole group of patients (15 patients).
Figure 11 Mean DVH of heart in 2D and 3D techniques in left sided breast cancer patients (8 patients).
Figure 12 Mean DVH of the left lung in 2D and 3D techniques in the whole group of patients (15 patients).
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was within tolerance (p< 0.001). In CBS cases the p value
was also <0.001.
Spinal cord
According to QUANTEC, 2010 guidelines, the D-max (the
maximum dose delivered) should be less than or equal to
50 Gy to avoid myelopathy which may occur in 0.2% of cases.
In 2D planning, the mean of the radiation dose to the spinal
cord was 119.114 cGy (SD± 172.409), while in 3D planning
the mean was 566.069 cGy (SD ± 1014.090).
In the whole group of patients, in the 3D technique, the D-
max was about 35 Gy, while in the 2D technique, the D-max
was about 7.5–8 Gy (p= 0.082) (Fig. 14).
Brachial plexus
In 2D planning, the mean of the radiation dose to the brachial
plexus was 2085.436 cGy (SD ± 1718.799), while in 3D plan-
ning the mean was 3393.856 cGy (SD± 1797.864).In the whole group of patients, in the 3D technique, the
maximum dose received by the brachial plexus was less than
55 Gy, as compared to 50 Gy in the 2D technique
(p< 0.001) (Fig. 15). Still, both doses were within known tol-
erance dose.
Discussion
In our study the coverage of the supraclavicular and infracla-
vicular regions was better with the 3D technique with less over
dose than the 2D technique, where 95% of the target was cov-
ered by 95% of the dose in 3D technique versus approximately
50% of target covered by 95% of dose. Over dose in 3D tech-
nique reached 110% of the dose (point dose) versus 122% in
2D (point dose) (p= 0.001). That difference was most evident
in coverage of the target in MRM cases where 95% of the tar-
get in the 3D technique is covered by 100% of the dose versus
only 20% in 2D technique (p= 0.002). While in CBS cases it
was 100% vs. 35% (p< 0.001).
We have concluded that for both the SCV and IFV nodes,
prescription of dose to a uniform depth of 3 cm in the 2D tech-
Figure 13 Mean DVH of the right lung in 2D and 3D techniques in the whole group of patients (15 patients).
Figure 14 Mean DVH of spinal cord in 2D and 3D techniques in the whole group of patients (15 patients).
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doses these regions compared with a conformal optimized
technique with deﬁnite localization of these nodes.
A similar ﬁnding was found regarding the coverage of the
chest wall or intact breast together with levels I and II of the
axilla.
This was comparable to what was concluded by Madu et al.
in a similar study conducted upon 20 patients with breast can-
cer, he concluded that coverage by the 90% isodose line in the
SCV was signiﬁcantly decreased with traditional planning ver-
sus conformal planning as the depth to the SCV nodes
increased (p= 0.001) [11].
Fields et al. had similar results when he compared the irra-
diation of the axillary apex and supraclavicular fossa in node
positive breast cancer traditionally treated with a single ante-
rior oblique beam with predeﬁned borders relative to bony
anatomy and matched to the breast or chest wall ﬁelds at a
plane beneath the head of the clavicle where plans were pre-
scribed to a median depth of 3 cm, versus an anterior wedged
pair 3D technique in regard to target coverage, he found that
the maximum dose in the treatment volume was 109.4% for
wedged pair 3D ﬁelds versus 108.1% for the 2D single oblique
ﬁeld (p= 0.1).Wedged pair ﬁelds had signiﬁcantly improved
prescription dose coverage of the target: 90% vs. 60%
(p< 105) [12].
Krasin et al. also evaluated the adequacy of a tangential
radiation technique in delivering dose to the breast and regio-
nal lymphatics. Adequate coverage of the breast was achievedin only 16 of 25 patients, with all patients having at least 85%
of the breast volume treated to 95% of the prescribed dose.
When the breast PTV was considered, only 2 patients were
found to have adequate coverage of the volume, but 20 of 25
patients had at least 80% of the breast PTV covered by 95%
isosurface .Only 1 patient (4%) had adequate coverage of
the Level I axilla, and no patient had adequate coverage of
the Level II or Level III axilla.
They explained the very bad coverage of the PTV in their
study by the possibility that their PTV margin was larger than
that required, and with a smaller margin, a better coverage
could be achieved [13].
That was consistent with the results achieved by Falahat-
pour et al. who concluded that by 2D plans, the mean values
of cold areas (less than 95%) and hot areas (more than
105%) were 26.4% and 8.1% respectively. These values were
reduced to 18.9% and 6.9% in 3D plans, respectively
(p< 0.000, p< 0.01). Dose homogeneity obtained was
65.4% in the 2D and improved to 74.8% in the 3D plans
(p< 0.000) [14].
In our study regarding the organs at risk, they received a
dose in the 3D technique that was more than that received in
the 2D technique (heart: p< 0.001, right lung: p< 0.001, left
lung: p< 0.001, brachial plexus: p< 0.001, spinal cord:
p= 0.082), again that difference was most evident in MRM
cases but all doses were still within tolerance except for the
right lung in cases with MRM which received the maximum
dose within tolerance stated by QUANTEC, 2010 [9].
Figure 15 Mean DVH of brachial plexus in 2D and 3D techniques in the whole group of patients (15 patients).
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nique in the supraclavicular region, and we added beam copies
and MLC segments in the plan of the breast/chest wall in order
to improve the target coverage, these multiple ﬁelds lead to
increased dose reaching the risk organs.
Moreover, we should also take into consideration the built
of our patients which affected markedly our results, most of
our patients are obese with large and wide chest wall or with
large pendulous breasts even after CBS, so for proper coverage
of our targets we used wider tangents with more volume of the
organs at risk included.
Also the heart in cases of left breast cancer received in the
3D technique the maximum possible dose within tolerance of
the cardiac muscle, above which long term cardiac mortality
could happen. This is also because of the wide tangents used
in 3D cases with more volume of the heart included
(p< 0.001).
That was consistent to the results concluded by Van der
Laan et al. when they compared 2D and 3D irradiation in
patients with left CBS, they found that the volume of the lungs
receiving >20 Gy (5.6% in 3D plan versus 4.2% in 2D plan),
and volume of the heart receiving >30 Gy (3.6% in 3D plan
versus 1.4% in 2D plan) were signiﬁcantly less with conven-
tional treatment plans (p= 0.006, <0.001 respectively), they
concluded also that CT-guided target deﬁnition and planning
resulted in higher doses delivered to the heart and lungs
because larger tangential beams were needed to include the
breast PTV [15].
On the other hand, Kong et al. concluded that application
of 3D planning for tangential breast irradiation did not
decrease heart and lung dose. There was no signiﬁcant differ-
ence between the 2D and the 3D plans regarding the dose
reaching the lungs or the heart [16].
That difference from our results may be due to that in the
study conducted by Kong et al., they included patients with
CBS only, and in these cases there is less difference in dose
reaching to lungs than MRM cases between 2D and 3D cases.
Also in our study, we had a worse coverage in 2D CBS cases
(80–85% only of target covered by more than 95% of the
dose), while Kong et al. had an average target coverage of
96%, and only 94% of their patients received more than
100% prescription dose, which accordingly lead to less differ-
ence in the dose reaching the lungs and heart between 2D and
3D cases [16].
Most of the literature for brachial plexus toxicity comes
from studies of head and neck or breast cancer. In a study thatevaluated the dose reaching the brachial plexus in lung cancer
patients, they concluded that the median dose to the brachial
plexus should be kept below 69 Gy and the maximum dose
to 2 cm3 below 75 Gy for patients with NSCLC [17].
Eblan et al. also stated that no radiation induced plexopa-
thy occurred in patients who received up to 78 Gy (Dmax) to
the ipsilateral brachial plexus [18].
The dose to brachial plexus, in our study, was found to be
less than 55 Gy, in the 3D technique as compared to 50 Gy in
the 2D technique (p< 0.001). In spite of that, both doses were
still within known tolerance also similarly Madu et al., studied
the dose reaching the brachial plexus and they concluded that
estimations of dose received to the brachial plexus for tradi-
tional versus optimized planning revealed that higher doses
are received to the plexus by using the optimized 3D plans [11].
This dose threshold is consistent with the 0–1% rate of bra-
chial plexopathy observed in patients treated with breast and
regional irradiation for breast-conserving therapy, where doses
of 46–50 Gy have been delivered to a traditional SCV ﬁeld to a
depth of 3 cm [19,20].
Thus, despite the delivery of a higher dose of radiation to
the brachial plexus volume by using the conformal optimized
technique, a higher rate of complications would not be
expected with the dose restricted to 50 Gy.
Fields et al. concluded that this far superior target coverage
of the axillary apex and SCV fossa by the 3D technique, came
at the cost of increased dose to OARs but without clinical cor-
relation where 2D technique delivered signiﬁcantly increased
doses to the cord than the 3D technique (Dmax 30.3 vs
20.6 Gy, (p< 105).
But there was no signiﬁcant difference for lung V20 (9.8%
vs 9.8%, p= 0.9) [12].
Conclusion and recommendations
The results of this study match the results of most of the liter-
ature published in this subject, that the coverage of the supra-
clavicular and infraclavicular PTV is signiﬁcantly worse with
the 2D technique using a single oblique ﬁeld at a ﬁxed depth
of 3 cm for all patients despite their different builts.
We recommend that in order to overcome this problem, we
should use an optimized 3D conformal technique, and if there
are no facilities to use conformal radiotherapy for all patients,
we should at least take CT cut at the center of the supraclavic-
ular ﬁeld to measure the approximate depth at which we
34 M. Barsoum et al.should do our 2D calculations and determine the proper beam
arrangement which we can use.
Further improvements are needed in the technique of the
3D plans in order to decrease dose reaching to the organs at
risk as much as we can.
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